Findings, by Endpoint | Study Design | ||||||
---|---|---|---|---|---|---|---|
Uncontrolled Clinical Trials | Non-Randomized Controlled Trials | Randomized Controlled Trials | |||||
Yoga Alone | Multiple Interventions | Yoga Alone | Multiple Interventions | Yoga Alone | Multiple Interventions | ||
Clinical endpoints | |||||||
Reduced need for medication | |||||||
Hypertension/CAD | [119] | [68] | [109, 121, 122]* | [80] | [130]* | [79]† | |
Diabetes | [91] | [92] [68] | [95] | ||||
Reduced revascularization procedures related complications† | [78] | ||||||
Number of subjects on treatment for: | |||||||
Hypertension (no difference)† | [79]† | ||||||
Other CVD complications (reduced)† | [79]† | ||||||
Reduced ECG evidence of ischemia† | [79]† | ||||||
Reduction in anginal episodes | [79]† [78] | ||||||
Reduced carotid intimal media thickness | [87] | ||||||
Reduced progression of CAD | [80] | [78] | |||||
Increased regression of CAD | [80] | [78] | |||||
Reduced number of serious coronary events | [129](NS)[79]† | ||||||
Reduced number of hospitalizations | [80] |
* With biofeedback.
† At 4 year follow up of individuals at risk for CVD; no difference in number of Ss currently on treatment for hypertension.
Abbreviations: CAD, coronary artery disease; CVD, cardiovascular disease.